One Turn Open the globe →Globe →

Health · Copenhagen, Denmark ·

Wegovy lowers BMI in children in trial

Novo Nordisk said Wegovy lowered BMI and obesity rates in children in a trial. No drug is approved for children under 12.

Why it matters

Younger children may gain a treatment option.

Background

Wegovy is approved for ages 12 and over.

The story so far

  1. Wegovy lowers BMI in children in trial
  2. Novo says Wegovy lowers BMI in children in trial

Follow the whole story →

Sources

This summary was written automatically from the reporting linked above; follow the sources for the full story. How One Turn works.

See it on the globe →All of Nov 16's stories

More on health